A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Valeo Pharma Says Physician Response Has Been Very Favourable To Company’s Asthma Drugs

AGORACOM Small Cap 60: Valeo Pharma Says Physician Response Has Been Very Favourable To Company’s Asthma Drugs

posted on Nov 25, 2021 01:42PM

Share
New Message
Please login to post a reply